Abstract: . . .  trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet . 1996;348:1329-39. 9. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor . N Engl J Med. 1994;330:956-61. 10. The EPILOG Investigators. Platelet glycoproteinn IIb-IIIa receptor blockade and low-dose heparin during PCI . N Engl J Med. 1997;336:1689-96. 11. Harrington R.A. Design and methodology of the PURSUIT trial . Am J Cardiol. 1997;80:34b-38b. 12. The PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for UA. N Engl J Med. 1998;338:1498-1505. 13. The PRISM-PLUS Study Investigators. Inhibition of the IIb/IIIa receptors with Tirofiban in UA and NQWMI . N Engl J. 1998;338:1488-1497. Page 6 14. The RESTORE Investigators. Effects of IIb/IIIa blockade with tirofiban in patients UA and NQWMI . Circulation. 1997;96:1445-53. 15. The PURSUIT Trial investigators. Inhibition of Platelets with Eptifibatide in ACS . N Eng J Med 1998; 339:436-443 16. Antman E.M., Cohen M et al . TIMI 11B - ESSENCE: Metaanalysis . Circulation 1999; 100: 1602-1608. 17. Braunwald E., Antman E., et al . ACC/AHA guidelines for the management of patients with unstable angina and non ST elevation myocardial infarction . J Am Coll Cardiol 2000; 36:970-1062. 18. Bertrand M.E., Simoons M.L. Acute coronary Syndromes: recommendations of the Task Force of the ESC . Eur Heart J 2000; 21:1406-32. 19. GRACE Project. A multinatinational registry . Am Heart J 2001;141:190-9.  . . .
--3000,1,1500,1946,16469